Drug: |
BGT226 |
|||
---|---|---|---|---|
Trial: |
A Phase I/II Study of BGT226 in Adult Patients With Advanced Solid Malignancies Including Patients With Advanced Breast Cancer |
|||
Conditions: | Solid Tumors | |||
Trial Status: |
Completed |
Massachusetts General Hospital55 Fruit Street |
Principal Investigator: |
Stephen Isakoff, MD |
---|---|
Contact: |
617-726-6225 nisaac1@partners.org |
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
Massachusetts General Hospital Website: |
http://www2.massgeneral.org/cancer/clinical_trials/adult/search_trials.asp |
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.